Trial Profile
Phase I human safety study of NUC B1000 in patients with chronic hepatitis B virus (HBV) infection
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 02 May 2014
Price :
$35
*
At a glance
- Drugs NUC B1000 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions